Cargando…
Assessment and characteristics of Erenumab therapy on migraine management
BACKGROUND: Migraine is one of the neurological diseases that have a negative impact on subjects’ productivity and daily activity of patients. Introducing monoclonal antibodies as a valuable option for resolving the persistent problem of migraine is still under investigation. The current study aimed...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508638/ https://www.ncbi.nlm.nih.gov/pubmed/36164568 http://dx.doi.org/10.1016/j.jsps.2022.06.015 |